Related Experiment Video
Updated: Dec 9, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Cardioprotective Effects of Dietary Flaxseed Post-Infarction Are Associated with Changes in MicroRNA Expression
Mihir Parikh1,2,3, Branislav Kura4, Kimberley A O'Hara1,2
1Department of Physiology and Pathophysiology, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 09J, Canada.
Abstract:
MicroRNAs (miRNAs/miRs) such as miR-1, miR-133a, miR-133b, miR-135a, and miR-29b play a key role in many cardiac pathological remodeling processes, including apoptosis, fibrosis, and arrhythmias, after a myocardial infarction (MI). Dietary flaxseed has demonstrated a protective effect against an MI. The present study was carried out to test the hypothesis that dietary flaxseed supplementation before and after an MI regulates the expression of above-mentioned miRNAs to produce its cardioprotective effect. Animals were randomized after inducing MI by coronary artery ligation into: (a) sham MI with normal chow, (b) MI with normal chow, and (c-e) MI supplemented with either 10% milled flaxseed, or 4.4% flax oil enriched in alpha-linolenic acid (ALA), or 0.44% flax lignan secoisolariciresinol diglucoside. The feeding protocol consisted of 2 weeks before and 8 weeks after the surgery. Dietary flax oil supplementation selectively upregulated the cardiac expression of miR-133a, miR-135a, and miR-29b. The levels of collagen I expression were reduced in the flax oil group. We conclude that miR-133a, miR-135a, and miR-29b are sensitive to dietary flax oil, likely due to its rich ALA content. The cardioprotective effect of flaxseed in an MI could be due to modulation of these miRNAs.
Insights
Dietary flaxseed oil, rich in alpha-linolenic acid (ALA), may protect the heart after myocardial infarction (MI) by regulating microRNAs (miRNAs). Supplementation upregulated miR-133a, miR-135a, and miR-29b, reducing cardiac fibrosis.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Nutritional Science
Background:
- MicroRNAs (miRNAs) are critical in cardiac remodeling post-myocardial infarction (MI), influencing apoptosis, fibrosis, and arrhythmias.
- Dietary flaxseed has shown cardioprotective effects against MI.
- The specific miRNA targets and mechanisms of flaxseed's cardioprotective action remain to be fully elucidated.
Purpose of the Study:
- To investigate whether dietary flaxseed supplementation modulates specific cardiac microRNAs (miRNAs) following myocardial infarction (MI).
- To test the hypothesis that flaxseed's cardioprotective effects are mediated by regulating miRNAs involved in cardiac remodeling.
Main Methods:
- Rats underwent MI induction via coronary artery ligation and were randomized into groups receiving sham surgery or MI with normal chow, milled flaxseed, flaxseed oil (rich in alpha-linolenic acid - ALA), or flaxseed lignans.
- Supplementation occurred for 2 weeks pre-surgery and 8 weeks post-surgery.
- Cardiac miRNA and collagen I expression levels were analyzed.
Main Results:
- Dietary flaxseed oil supplementation selectively upregulated cardiac expression of miR-133a, miR-135a, and miR-29b.
- The flaxseed oil group exhibited reduced levels of collagen I expression, indicating decreased cardiac fibrosis.
- Milled flaxseed and flax lignan supplementation did not show the same specific miRNA upregulation or collagen reduction.
Conclusions:
- miR-133a, miR-135a, and miR-29b are sensitive to dietary flaxseed oil, likely due to its high alpha-linolenic acid (ALA) content.
- Flaxseed oil's cardioprotective effects post-MI may be attributed to its ability to modulate these specific miRNAs.
- These findings highlight a potential nutritional strategy for managing cardiac remodeling after MI through miRNA regulation.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022